Enabling Farmers to Improve Agricultural Prosperity in Africa
AGCO, Your Agriculture Company (NYSE:AGCO), a worldwide manufacturer and distributor of agricultural equipment, today held its sixth annual AGCO Africa Summit in Berlin, Germany. A joint initiative of AGCO, Bayer CropScience, Rabobank, De Lage Landen, Trelleborg and Fuse Connected Services, this year’s Summit focused on ‘Organizing Farmers of the Future.’
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170123005509/en/
Rob Smith, AGCO Senior Vice President and General Manager, Europe and Middle East (EME); Christian Wulff, Former Federal President of Germany and Gary Collar, AGCO Senior Vice President and General Manager Asia Pacific and Africa (APA) at the AGCO Africa Summit 2017. (Photo: Business Wire)
“Co-operation among farmers has proven advantages in the advancement of agriculture,” says Gary Collar, AGCO Senior Vice President, Asia Pacific and Africa. “As well as giving farmers a voice and pushing for beneficial policies from the grassroots, collaboration can help achieve economies of scale and facilitate access to inputs, credit and markets. Today, technology, particularly through the proliferation of mobile phones and social media in Africa, is providing one of the greatest-ever opportunities for groups to organize themselves into powerful, influential bodies.”
Keynote speakers at the event included Christian Schmidt, Germany’s Federal Minister of Food and Agriculture, Elsie Kanza, Head of Africa, World Economic Forum, Christian Wulff, Former Federal President of Germany and Dr Agnes Kalibata, President of AGRA (Alliance for a Green Revolution in Africa).
Through presentations and panel discussions, the Summit explored how agribusiness and farmer-based organizations can be aligned as co-creators of rural wealth; how youth and Information and Communication Technology (ITC) can catalyze the organization of farmers in the future, and how maximum ‘value’ can be secured from the value chains for the farmers who participate in them.
Among the panelists were figures from farmer organizations in Africa and Europe including Dr. Theo de Jager, President Pan African Farmers’ Organization, Joachim Rukwied, President German Farmers’ Association, Ishmael Sunga, CEO Southern African Confederation of Agricultural Unions and Jehiel Oliver, CEO and Founder of Hello Tractor, an innovative shared-economy platform that makes tractor usage affordable to marginalized farmers in sub-Saharan Africa.
“AGCO is investing significantly in Africa and growing its local presence there by providing African farmers and African agribusinesses with comprehensive agricultural solutions,” says Nuradin Osman, AGCO Vice President and General Manager Africa. “The Company is committed to the transformation of African agriculture based on a strategy of inclusive and sustainable farm mechanization. In 2017, we will be retaining a strong focus and investment in small-scale agriculture, as well as leading the way in high-tech solutions for commercial farmers on the continent.”
Since its premiere in 2012, this AGCO Africa Summit has established itself as an important institution for discussing critical issues impacting Africa’s agricultural development. The Summit has a strong focus on private sector-driven agricultural growth, promoting the idea of agriculture as a business and not a development agenda. The focus of panel topics, discussions and workshops engage with practical real-life examples of leading edge projects and initiatives. The international conference attracts CEOs, industry experts and political leaders with a common interest to accelerate the development of African agriculture.
AGCO (NYSE: AGCO) is a global leader in the design, manufacture and distribution of agricultural solutions and supports more productive farming through its full line of equipment and related services. AGCO products are sold through five core brands, Challenger®, Fendt®, GSI®, Massey Ferguson® and Valtra®, supported by Fuse® precision technologies and farm optimization services, and are distributed globally through a combination of approximately 3,000 independent dealers and distributors in more than 140 countries. Founded in 1990, AGCO is headquartered in Duluth, GA, USA. In 2015, AGCO had net sales of $7.5 billion. For more information, visit http://www.AGCOcorp.com. For company news, information and events, please follow us on Twitter: @AGCOCorp. For financial news on Twitter, please follow the hashtag #AGCOIR.
Manager External Affairs, Africa
Mobile UK: +44 (0)7789 746268
Mobile Zambia: +260 (0)971398169
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Seoul Semiconductor’s SunLike Series LEDs Win Product of the Year Award from Elektronik Magazine23.3.2018 18:28 | Pressemelding
Seoul Semiconductor, a global innovator of LED products and technology, announced on March 23rd that its SunLike Series natural spectrum LED product won the Gold Award at the Elektronik Product of the Year 2018 Awards, hosted by Elektronik (http://www.elektroniknet.de), a leading German electronics publication. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180323005646/en/ Product of the Year Award from Elektronik Magazine (SunLike) (Photo: Business Wire) As a publication specializing in electrical and electronic components, “Elektronik” is a prestigious magazine with an illustrious history and the largest number of subscribers in Germany. Over the past 20 years, they have conducted annual surveys among their subscribers to find the “most creative and innovative products.” Based on these survey results, Elektronik selects the top product that with the most impact in its corresponding field, and confers the awards accordingl
Elliott Welcomes Imminent Bezeq Board Overhaul and New Era for Strong Independent Governance23.3.2018 16:05 | Pressemelding
Elliott Advisors (UK) Limited (“Elliott”), which advises funds which collectively hold a significant economic interest in Bezeq The Israeli Telecommunication Corporation Ltd. (“Bezeq” or the “Company”), welcomes the proposed governance reforms announced by Bezeq last night. In its initial letter to Bezeq Interim Chairman David Granot, dated January 16, 2018, Elliott outlined the urgent need to address the Company’s serious corporate governance issues, and called for changes at the Board level that result in “the right mixture of expertise, independence and integrity for the future.” Elliott stated then, and reiterates now, its belief that “there is significant value to be unlocked if the right steps are taken to improve its corporate governance.” Bezeq has strong business fundamentals, an exemplary workforce, and great potential. Following yesterday’s announcement, Elliott highlights the changes that have occurred since January 16th. Taken together, these amount to a revolution in the
Clovis Oncology Initiates Early Access Program for Rucaparib as Treatment and as Maintenance Therapy in Recurrent Ovarian Cancer in Europe23.3.2018 12:52 | Pressemelding
Clovis Oncology, Inc. (NASDAQ:CLVS) today announced the initiation of an early access program in Europe for rucaparib for treatment and as maintenance therapy in recurrent ovarian cancer. The program will be overseen and implemented by Caligor Coghlan, which specializes in early access to medicines. The program, to be known as the Rucaparib Access Program (RAP), will enable participation from certain countries in Europe, where permitted by applicable rules, procedures and regulatory authorities. The RAP protocol allows for rucaparib treatment of an individual patient with third-line or greater BRCA mutant epithelial, fallopian tube, or primary peritoneal ovarian cancer who has platinum-sensitive disease and is unable to tolerate further platinum-based chemotherapy or has platinum-resistant disease and needs treatment with single agent rucaparib. The RAP protocol will also provide access to rucaparib for maintenance therapy of an individual patient with recurrent epithelial ovarian, fal
CHMP Grants Positive Opinion for Clovis Oncology’s Rubraca® (rucaparib) Tablets23.3.2018 12:50 | Pressemelding
Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that the European Union’s (EU) European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a conditional marketing authorization for Rubraca as monotherapy treatment of adult patients with platinum sensitive, relapsed or progressive, BRCA mutated (germline and/or somatic), high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have been treated with two or more prior lines of platinum based chemotherapy, and who are unable to tolerate further platinum based chemotherapy. The European Marketing Authorization application for the treatment indication was based on objective response rate and duration of response results from two multicenter, single-arm, open-label clinical trials, Study 10 and ARIEL2, in women with advanced BRCA mutant ovarian cancer who had progressed after two or more prior chemotherapies. “The recommendation
Janssen Announces Positive CHMP Opinion for JULUCATM▼ (dolutegravir/rilpivirine)23.3.2018 12:46 | Pressemelding
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommending marketing authorisation for JULUCA™ (dolutegravir 50mg [ViiV Healthcare UK Ltd]/rilpivirine 25mg [Janssen Sciences Ireland UC]). Dolutegravir/rilpivirine is a single-pill, two-drug regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 c/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor (NNRTI) or integrase strand transfer inhibitor (INSTI).1 “We are delighted to be one step closer to bringing JULUCA™ to people living with HIV in Europe,” said Mathai Mammen, M.D., Ph.D., Global Head, Janssen Research & Development, LLC. “Building on our 25-year c
Aitheon Executives Educate World Leaders on Benefits, Challenges of AI at the Annual World Government Summit in Dubai23.3.2018 12:00 | Pressemelding
Aitheon, makers of the world’s first blockchain-powered platform to solve real problems by integrating AI, robotics, IoT, human specialists and cryptocurrency, announced today that executives from the company held a series of high-level briefings with world leaders at the Annual World Government Summit in Dubai. Briefings covered the benefits and challenges of AI, and revolutionary new solutions to world challenges made possible by transformative new technologies. (Read the full release at www.aitheon.com/news) This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180323005269/en/ Aitheon founder and CEO, Andrew Archer, and Chief Strategy Officer, Ryan Burleson, were invited to brief leaders at the Summit by Cyrus Hodes, Co-founder and Director of the AI Initiative, an undertaking of the Future Society at Harvard University’s Kennedy School. Archer and Burleson addressed a variety of AI-related topics, including the impact of AI on